Device Trial Radar · NCT01253356
ACTIONS - Aortic Counterpulsation to Improve Outcomes in Noncardiac Surgery
Last checked: Nov 19, 2026Latest source record: Jan 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1
Actual
Start
Jan 2011
Primary completion
Jan 2012
Study completion Feb 2012
Sponsor
- Lead sponsor
- Datascope Corp.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 3, 2010
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The use of the IABP, in addition to standard care, in high-risk cardiac patients undergoing major noncardiac surgery is feasible and may result in improved perioperative outcomes at 30 days compared with standard care alone, while maintaining acceptable safety with respect to vascular accesss-related complications.
Conditions
- Patients With History of Ischemic Heart Disease With LV Dysfunction Undergoing Noncardiac Surgery
Interventions
IABPDevice
Insertion of intra-aortic balloon \< or = 3 hours before noncardiac surgery and maintained \> or = 12-24 hours after surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- SafetyTime frame: 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Genesis Medical Center
Davenport, Iowa
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.